Marquee Middle Image

Faculty Profile

Allan T. Bombard, M.D.

Dr. Allan T. Bombard
 

Selected Publications

Published Abstracts and Presentations:

 

1.                  Bombard, AT, Hauth, JC, Gilstrap, LC III (1982): Preg­nan­cy outcome in adoles­cents. Proceed­ings of the Twenty-­first Annual ACOG Armed Forces District Meeting. Portland, Ore­gon.

2.                  Bombard, AT, Saunders, TR (1983): A non‑surgical ap­proach to the vesico­vaginal fistula. Proceedings of the Twenty-­second Annual ACOG Armed Forces District Meeting. Las Vegas, Nevada.

3.                  Bombard, AT, Hauth, JC, Trabal, JF, Mitchell, MD, Strick­land, DM (1983): Prostaglan­din E2 in periton­eal fluid of women with endome­trio­sis. Proceedings of the Twen­ty‑­second Annual ACOG Armed Forces District Meeting. Las Vegas, Nevada.

4.                  Bombard, AT, Simpson, JL, Martin, AO, Elias, S, Verp, MS (1984): 45,X/46,XX Mosaicism and secon­dary amenorrhea. Proceed­ings of the Twen­ty‑third Annual ACOG Armed Forces District Meeting. Atlan­ta, Georgia.

5.                  Ober, C, Kostyu, D, Elias, S, Bombard, AT, Simpson, JL, Mar­tin, AO (1985): Spontane­ous abortion and HLA‑DR sharing: Popula­tion‑based studies in Hutterite couples. Sixth Annual Sym­posium of the American Society for Immunol­ogy of Repro­duction. Ann Arbor, Michigan.

6.                  Bombard, AT, Elias, S, Simpson, JL, and Martin, AO (198­5): Chor­ionic villus sampling in continuing pregnancies. Proceedings of the Twen­ty‑fourth Annual ACOG Armed Forces District Meeting. New Orleans, Louisiana.

7.                  Strickland, DM, Bombard, AT, Trabal, JF, Mitchell, MD (1985): The modulation of prostaglandin syn­thesis by peritoneal fluids. Proceedings of the Twenty‑fourth Annual ACOG Armed Forces District Meeting. New Orleans, Louisi­ana.

8.                  Elias, S, Simpson, JL, Martin, AO, Sabbagha, RE, Bombard, AT, Rosinsky, BR, Baum, LD (1985): Chorionic villus sam­pling in continu­ing preg­nancies: I. Surgical techniques as­sociated with low fetal loss rates in initial 109 cases. Fifty‑­third Annual Meeting of the Central As­sociation of Obstetricians and Gyne­colo­gists. New Orleans, Louisi­ana.

9.                  Simpson, JL, Martin, AO, Bombard, AT, and Elias, S (198­5): How frequent are chromosomal abnormalities in spon­taneous abor­tuses? Reassess­ment on the basis of chorionic villus vs. embry­onic cul­tures. Am J Hum Genet 37(4): A117.

10.              Bombard, AT, Elias, S, Simpson, JL, Martin, AO, Ro­sin­sky, BJ, Paul, M (1986): Prenatal diagnosis in the first trimester: Justified for carriers of balanced homolo­gous trans­locations? Pro­ceedings of the Twen­ty­‑fifth Annual ACOG Armed Forces Dis­trict Meet­ing. San Diego, California.

11.              Bombard, AT, Baum, LD, Simpson, JL, Marder, R (1986): Maternal Serum alpha‑feto­protein (MSAFP) screening: The North­west­ern University experience. Proceedings of the Twenty‑­fifth Annual ACOG Armed Forces District Meeting. San Diego, California.

12.              Ober, C, Elias, S, O’Brien, E, Kostyu, D, Hauck, W, Bombard, A (1986): Prenatal histocompatibili­ty selection and maintenance of HLA polymorphism. 7th International Congress of Human Genetics. Berlin, Federal Republic of Germany.

13.              Bombard, AT, Charrow, JM, Hvizd, MG and Patrissi, GA (1987): Non-Jewish spouses: A new group at risk for Tay-Sachs disease? Pro­ceed­ings of the Twenty-sixth Annual ACOG Armed Forces District Meet­ing. Denver, Colorado.

14.              Bombard, AT, Rigdon, DR, Burkhardt, WC, Flanagan, JC and Thompson, BH (1987): Genetic counseling for prenatal diagnosis. Proceed­ings of the Twenty-sixth Annual ACOG Armed Forces District Meeting. Denver, Colorado.

15.              Verp, MS, Bombard, AT, Simpson, JL, Elias, S and Martin, AO (1987): Parental decision following prenatal diagnosis of fetal a chromosome abnor­mality. Am J Hum Genet 41(3):A286.

16.              Bombard, AT (1987): Basic clinical cytogenetics, Contem­porary tech­niques for prenatal diagnosis and Antenatal surveillance for neural tube defects. USUHS Symposium on Perinatal Medicine. Heidelberg, Federal Republic of Germany.

17.              Bombard, AT (1987): Genetics for the obstetrician/gynecol­o­gist and Funda­mentals of genetic counseling. Symposium on Genetics in Clinical Practice American College of Obstetri­cians and Gynecolo­gists, Dis­trict VII Annual Meeting. Point Clear, Alabama.

18.              Sharp, GH, Bombard, AT and Roberts, WE (1988): Obstet­ric manage­ment of neural tube defects: A ten year review. Proceedings of the 36th Annual Society of Air Force Clinical Surgeons Meet­ing, Oakland, California.

19.              Bombard, AT, Rigdon, DT and Flanagan, JC (1988): Maternal serum alpha-fetoprotein screening: The Keesler experience. Proceedings of the 36th Annual Society of Air Force Clin­ical Surgeons Meeting, Oakland, California.

20.              Bombard, AT, Rigdon, DT, Roberts, WE and Anderson, RL (1988): “Conserva­tive” in utero management of a fetus with genitourinary anomalies. Proceedings of the 36th Annual Society of Air Force Clinical Surgeons Meeting, Oakland, California.

21.              Rigdon, DT, Bombard, AT, Flanagan, JC and Burkhardt, WC: Prenatal diagnosis in twins: Balanced and unbalanced reciprocal trans­location in viable and non-viable co-twins, respectively. Proceedings of the 11th Annual Southern Genetics Group Meeting. Navarre Beach, Florida.

22.              Bombard, AT, Rigdon, DT and Bartholomew, DW (1988): Analysis of indica­tions for referral to a multispecialty genetics clinic. Proceed­ings of the Twenty-seventh Annual ACOG Armed Forces District meeting. San Antonio, Texas.

23.              McCool, RA, Garner, WL, Bombard, AT and Roberts, WE (1988): Assessment of obstetric ultrasound services in a ter­tiary mili­tary medical referral center. Proceedings of the Twenty-seventh Annual ACOG Armed Forces District meet­ing. San Antonio, Texas.

24.              Morrow, GK, Bombard, AT and Rigdon, DT (1988): Aber­rant parental chromosom­al complements: A 3 year assessment of patients referred for cytoge­netic evaluation from mili­tary infertility clinics. Proceedings of the Twenty-seventh Annual ACOG Armed Forces District meeting. San Antonio, Texas.

25.              Bartholomew, D, Rigdon, D, McLean, K, and Bombard, A (1988): Identi­fication of anonymous chromosome fragment 14p+ using gene-dosage effect for peptidase-A. Proceedings of the Society of Air Force Physicians.

26.              Bombard, AT (1988): Clinical perspectives on MSAFP screen­ing. Society of Armed Forces Medical Laboratory Scientists Meeting. Reno, Nevada.


27.              McCool, RA, Bombard, AT, Hess, LW, and Rushing, WR (1989): Congenital cellular immunodeficiency with lymphopenia and thymic hypoplasia (Nezelof syndrome): A case report. Proceedings of the Twenty-eighth Annual ACOG Armed Forces District meeting. Washing­ton, D.C.

28.              Naef, RW, Bombard, AT, Pruitt, L, Rigdon, DT, and Barthol­omew, DW (1989): Ultrasono­graphic findings of fetal pleural effusion and intra­uterine growth retardation indicate risk for fetal trisomy 18. Proceedings of the Twenty-eighth Annual ACOG Armed Forces District meeting. Washing­ton, D.C.

29.              Bom­bard, AT, Williams, TC, Rigdon, DT, and Bartholomew, DW (1989): Effi­ciency of amniocyte karyotyping: A prospective comparison of the in-situ method with traditional cell culture technique. Proceedings of the Twenty-eighth Annual ACOG Armed Forces Dis­trict meeting. Washing­ton, D.C.

(Winning paper, Host Award for Best Clinical Paper, AFD/ACOG 1989.) (1990 Purdue-Frederick Award, ACOG/ACM, 2nd Place.)

30.              Britton, LC, Bombard, AT, Rigdon, DT, Broderick, RD, and Maha, GC (1989): Reduced amniotic fluid alpha-fetoprotein (AF-AFP) levels and cyto­genetic abnormalities: Are they related? Proceedings of the Twenty-eighth Annual ACOG Armed Forces Dis­trict meeting. Washing­ton, D.C.

(Winning Paper, Best Obstetric Paper by a Resident, AFD/ACOG 1989.)

31.              Shel­burne, PV and Bombard, AT (1989): Simple database management for Ob-Gyn cases using the Macintosh: Applications to board examination preparation and resident education. Proceedings of the Twenty-eighth Annual ACOG Armed Forces District meeting. Washing­ton, D.C.

32.              Bombard, AT (1989): Benefits of Maternal Serum Alpha-Fetoprotein Screening. Sympo­sium on Repro­ductive Genetics at the Twenty-eighth Annual ACOG Armed Forces District meeting. Washing­ton, D.C.

33.              Ali, RN, Shelburne, PV, Roberts, WE, and Bombard, AT (1989): Pregnancy complicated by severe preeclampsia and hemoglobin M disease: A case report. Proceed­ings of the Twenty-eighth Annual ACOG Armed Forces District meeting. Washing­ton, D.C.

34.              Bombard, AT (1990): Prenatal Diagnosis: Maternal Serum Screening in Contem­porary Obstetric Practice. Grand Rounds, Tripler Army Medical Center. Honolu­lu, Hawaii.

35.              Bombard, AT (1990): Prenatal Diagnosis: Maternal Serum Screening. A Summary of Past Developments and a Look to the Future. Grand Rounds, The University of South Alabama. Mobile, Alabama.

36.              Bombard, AT (1990): Invited Faculty Lecturer, USUHS 41st Military Medical-Surgical Clinical Congress. 21-25 May. Garmisch, Federal Republic of Germany.

37.              Bombard, AT (1991): Invited Faculty: Prenatal diagnosis and Maternal serum screening: A summary of past developments and a look to the future. 39th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists. New Orleans, Louisiana.

38.              Brennan, M., Calhoun, BC, Bombard, AT, and Roberts, WE (1991): Revised Management of ITP in Pregnancy. Proceed­ings of the Twenty-ninth Annual ACOG Armed Forces District meeting. Cincinnati, Ohio.

39.              McCool, RA, Bombard, AT, Locker, BK, and Calhoun, BC (1991): The association of unexplained/elevated MSAFP (Maternal Serum Alpha-FetoProtein) screening and placenta increta: A case report. Proceed­ings of the Twenty-ninth Annual ACOG Armed Forces District meeting. Cincinnati, Ohio.

40.              Bombard, AT and Bartholomew, DW (1991): Molecular analysis following CVS: A case report and model for rapid prenatal diagnosis of single gene disorders in military medicine. Proceed­ings of the Twenty-ninth Annual ACOG Armed Forces District meeting. Cincinnati, Ohio.

41.              Bombard, AT and Rigdon, DT (1991): A prospective pilot evaluation of early (11-14 weeks’ gestation) amniocentesis in 75 patients. Proceed­ings of the Twenty-ninth Annual ACOG Armed Forces District meeting. Cincinnati, Ohio.

(Winning Paper, Chairman’s Award for Best Obstetrics Paper Presentation from a Teaching Hospital, AFD/ACOG 1991.)

42.              George, DC, Bartholomew, DA, and Bombard, AT: Clinical and pathologic correla­tions of peri-operative exogenous and endogenous estrogen administration in post-menopausal women. Proceed­ings of the Twenty-ninth Annual ACOG Armed Forces District meeting. Cincinnati, Ohio.

43.              Calhoun, BC, Naef, RW and Bombard, AT (1991): Prevalence of fetal macrosomia in a military medical center obstetric service. Proceedings of the 11th Annual Society of Perinatal Obstetricians Meeting. Am J Obstet Gynecol 164(1):395.

44.              Bombard, AT, Bartho­lomew, DW, Neeno, TA, and Rig­don, DT (1991): Value of mouth-washings as a source for heterozygote DNA analysis by PCR: Com­parison to pe­ri­pheral blood. Proceedings of the 11th Annual Society of Perinatal Obste­tricians Meeting. Am J Obstet Gynecol 164(1):351.

45.              Bombard, AT (1991): Invited Faculty, Mater­nal serum screening for fetal genetic diseases. Grand Rounds presentation, Department of Obstetrics & Gynecology, Albert Einstein College of Medicine/Montefiore Medical Center. Bronx, New York.

46.              Bombard, AT (1991): Invited Faculty, University of South Alabama Perinatal Symposium. Fetal monitoring; Diagnostic techniques and strategies for the 1990’s: Mater­nal serum protein screening in early pregnancy. Mobile, Alabama.

47.              Bombard, AT (1992): Keynote Speaker, Gynestic Society of Mississippi. Jackson, Mississippi.

48.              Bombard, AT (1992): Advances in reproductive genetics. Visiting Professor, Grand Rounds University of Mississippi Medical Center. Jackson, Mississippi.

49.              Bombard, AT (1992): Invited Faculty, Universi­ty of South Ala­bama Third Annual Conference on A Multidisciplinary Approach to the High Risk Patient. Screening for Genetic Disease. Mobile, Alabama.

50.              Bombard, AT (1992): Invited Faculty: Maternal Serum Screening/Obstetrics. 40th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Las Vegas, Nevada.

51.              Bombard, AT (1992): Invited Faculty: Prenatal Diagnosis Techniques. 40th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Las Vegas, Nevada.

52.              Bledsoe, M, Bombard, AT, Calhoun, BC (1992): Prospective evaluation of early genetic amniocentesis: Evidence for respiratory compromise? Proceed­ings of the Thirtieth Annual ACOG Armed Forces District Meeting. Norfolk, Virginia.

53.              Bombard, AT (1993): Invited Faculty: Advances in Reproductive Genetics and Maternal Serum Oncofetal Antigen Screening. 41st Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Washington, DC.

54.              Sachs, GS, Bombard, AT, Nitowsky, HM (1993): The misuse of Cytotec - a potential teratogen. Program Abstracts of the Thirty Third Annual Teratology Society Meeting. Teratology 47:404 (A75).

55.              Bombard, AT, Powers, JF, Ben-Yishay, M, Nakagawa, S, Nitowsky, HM (1993): Management of the Acetylcholinesterase-Positive Amniocentesis Patient: Experience with 20,000 Surgical Procedures. Proceedings of the American College of Surgeons. 79th Annual Clinical Congress. San Francisco, California. p. 197.

56.              Bombard, AT, Sachs, G, Nakagawa, S, Carter, SM, Cohen, BL, Runowicz, CD, Eluma, FO, Nitowsky, HM (1993): Unusual maternal serum oncofetal antigen screening results as a risk factor for abdominal pregnancy: An unreported relationship. Proceedings of the American Society of Human Genetics. 43rd Annual Meeting. New Orleans, Louisiana. Am J Hum Genet 53:A1383.

57.              Eluma, FO, Bombard, AT, Runowicz, CD, Nakagawa, S, Mikhail, MS, Moure­house, H, Nitowsky, HM (1993): Abdominal pregnancy elucidated through maternal serum oncofetal antigen screening: Illustrations of serendipitous early diagnosis. Proceedings of the 31st Annual ACOG Armed Forces District Meeting. Seattle, Washington.

58.              Finn-Powers J, Carter SM, Schwartz A, Bombard AT (1994): Procedure-related loss rate in transplacental versus non-transplacental amniocentesis. Proceedings of the 14th annual Society of Perinatal Obstetricians meeting. Las Vegas, Nevada. Am J Obstet Gynecol 170:348(A255).

59.              Carter S, Finn-Powers J, Schwartz A, Bombard AT (1994): Does the presence of occult subchorionic hematomas influence outcome following genetic amniocentesis? Proceedings of the First annual American College of Medical Genetics Clinical Meeting. Orlan­do, Florida.

60.              Bombard, AT (1994): The Genetics of Aging: Impact on Women’s Health Care. Grand Rounds, The University of South Alabama. Mobile, Alabama.

61.              Bombard, AT (1994): Invited Faculty: Prenatal Genetic Screening. 42nd Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Orlando, Florida.

62.              Ben-Yishay M, Bombard AT, Fields AL, Runowicz CD (1994): Genetic counseling for ovarian cancer: On the development and implementation of a multi-disciplinary model. Proceedings of the American Society of Human Genetics. 44th Annual Meeting. Montreal, Province of Quebec. Am J Hum Genet 55(3):#804;A140.

63.              Javed AA, Huang Y, Bombard, AT (1994): Vitamin D receptor alleles: Cloning and characterization of the VDR gene and RT-PCR of VDR cDNA. Proceedings of the American Society of Human Genetics. 44th Annual Meeting. Montreal, Province of Quebec. Am J Hum Genet 55(3):#1910;A326.

 

64.              Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin G, Mueenuddin M, Bombard A: Triple marker (AFP, uE3, hCG) screening versus AFP plus free-beta in second trimester maternal serum screening for Down syndrome: A prospective comparison study. Proceedings of the 15th annual Society of Perinatal Obstetricians meeting. Am J Obstet Gynecol. 172(1):A476.

65.              Bombard AT (1995): Invited Faculty: Screening for Genetic Disease in Pregnancy. 43rd Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. San Francisco, California.

66.              Bombard AT (1995): Invited Faculty: Update on Prenatal Diagnosis. 43rd Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. San Francisco, California.

67.              Cardonick EH, Bombard AT, Carter SM, Abruzzo-Fogarassy M, Barad DH, and Nitowsky HM (1995): Unexplained increased maternal serum alpha-fetoprotein: The value of multiple marker analysis trending in predicting adverse pregnancy outcome. Albert Einstein College of Medicine, Resident Research Project Presentation. Bronx, New York.

68.              Bombard AT (1995): Update on Prenatal Diagnosis; Screening for Genetic Disease in Pregnancy. Grand Rounds, Department of Obstetrics & Gynecology. Eastern Carolina University. Greenville, North Carolina.

69.              Hinds L, Cardiero D, Bombard AT: Obstetrician’s current use of and attitudes toward maternal serum marker screening. Proceedings of the American Society of Human Genetics. 45th Annual Meeting. Minneapolis, Minnesota. Am J Hum Genet 57(4):A296, #1721.

70.              Bombard AT (1995): Maternal Serum Screening in the 90’s. Grand Rounds, Department of Obstetrics & Gynecology. Wilford Hall USAF Medical Center, Lackland AFB, San Antonio, Texas.

71.              Bombard AT (1995): Genetics. Ob-Gyn Pathology-Oncology-Genetics-Endocrin­ology & Current Obstetrics. 18th Annual Microscopic & Clinical Review. New Orleans, Louisiana.

72.              Bombard AT (1996): Screening for Fetal Aneuploidy: Evolution of Current Standards and a Look to the Future. Grand Rounds, Department of Obstetrics & Gynecology. Sinai Hospital. Baltimore, Maryland.

73.              Kellner LH, Canick JA, Saller DN, Palomaki GE, Neuer M, Osanthanondh R, Bombard AT (1996): Second Trimester Levels of Maternal Urinary Total Estriol (TE3) in Down Syndrome Pregnancy. Recent Advances in Prenatal Diagnosis for Aneuploidy. Amsterdam, Netherlands.

74.              Kellner LH, Canick JA, Palomaki GE, Neuer M, Saller DN, Walker RP, Osathanondh R, Bombard AT (1996): Maternal urine screening for fetal Down syndrome: Compari­son of beta-core fragment, free-beta subunit, and hCG. Proceedings of the 16th Annual Society of Perinatal Obstetricians meeting. Hilo, Hawaii. Am J Obstet Gynecol 174(1):A446, #498.

75.              Cardonick EH, Bombard AT, Gross SJ, Carter SM, Abruzzo-Fogarassi M, Barad DH, Nitowsky HM (1996): Unexplained increased maternal serum alpha-feto­protein: The value of multiple marker analysis trending in predicting adverse pregnancy outcome. Proceedings of the 16th Annual Society of Perinatal Obstetricians meeting. Hilo, Hawaii. Am J Obstet Gynecol 174(1):A436, #457.

 

76.              Roberts J, Bombard A, Gross S, Laks M, Pulijaal V, Nitowsky H (1996): Comparing the rate of detection of translocation-trisomy 21 with the rate of detection of trisomy 21 with decreased MSAFP. Proceedings of the 16th Annual Society of Perinatal Obstetricians meeting. Hilo, Hawaii. Am J Obstet Gynecol 174(1):A437, #462.

77.              Kellner LH, Canick JA, Saller DN, Palomaki GE, Neuer M, Osathanondh R, Bombard AT (1996): Second trimester levels of maternal urinary total estriol (TE3) in Down syndrome pregnancy. Proceedings of the Recent Advances in Prenatal Diagnosis for Aneuploidy meeting. Amsterdam, The Netherlands. Abs. #15.

78.              Bombard AT (1996): Screening for Fetal Aneuploidy: Evolution of Current Standards and a Look to the Future. Centro Genética Clínica, 3o Simpósio: Diagnóstico Pré-Natal e Rastreio de Malfomações. Lisbon, Portugal.

79.              Bombard AT (1996): Screening for genetic disorders in pregnancy; Latest update on genetics. First Biennial Perinatal Conference, Trover Clinic Foundation/March of Dimes. May, Madisonville, Kentucky.

80.              Freda MC, DeVore N, Adams R, Bombard AT, Merkatz IR (1996): Do pregnant women know enough about MSAFP testing to sign informed consent? Proceedings of the American Public Health Association annual conference. San Diego, California.

81.              Bombard AT, Kellner LH, Merkatz IR, Nitowsky HM (1997): Managing genetics care: Restructuring the paradigm for academic medical centers. South East Regional Genetics Group (SERGG) meeting; July, 1996. Ft Walton Beach, Florida and the Proc Greenwood Genet Cen. Process Greenwood Genet Cen 16:270.

82.              Bombard AT (1996): Screening for Genetic Diseases in Obstetrics and Gynecology Grand Rounds, Department of Obstetrics & Gynecology, Vanderbilt University. Nashville, Tennessee.

83.              Bombard AT (1996): Invited Faculty. Re-Engineering Academic Medicine: Popula­tion Screening for Genetic Diseases in Obstetrics and Gynecology. Annual meeting of the American College of Obstetricians and Gynecologists Armed Forces District. October, Nashville, Tennessee.

84.              Bombard AT, Kellner LH, Kapel AS, Brown MA, Merkatz IR, Nitowsky HM (1996): Re-engineering the academic medical center: Reproductive genetics as a model for implementing consumer-focused services. Am J Hum Genet 59:A332 #1940.

85.              Kellner LH, Canick JA, Palomaki GE, Saller DN, Lambert-Messerlian GM, Neuer M, Osathanondh R, Bombard AT (1996): Urinary markers: A new approach in screening for fetal Down syndrome in the second trimester. Am J Hum Genet 59:A41 #207.

86.              Bernstein P, Gross SJ, Cohen DJ, Tiller GR, Shanske AL, Bombard AT, Marion RW: Prenatal diagnosis of Pfeiffer syndrome (PS), type 2. Am J Hum Genet 59:A317 #1842.

87.              Sullivan S, Coker T, Joseph A, Mensing D, Kellner L H, Pulijaal V, Bombard AT, Cantarero I. Chromosome 21 ploidy assessment within one hour via un-amplified FISH methodology. Am J Hum Genet 59:A331 #1926.

88.              Bombard AT (1996): Genetics: Clinical Cytogenetics, Molecular Genetics, and Screening for Fetal Genetic Disease. Ob-Gyn Pathology-Oncology-Genetics-Endocrin­ology & Current Obstetrics. 19th Annual Microscopic & Clinical Review. Wesley-Columbia Medical Center. October, New Orleans, Louisiana.

89.              Bombard AT (1996): Maternal Serum (and Other) Screening for Fetal Aneuploidy. Grand Rounds, Department of Obstetrics & Gynecology. New York Hospital/Cornell University. New York, New York.

90.              Bombard AT (1996): Invited Faculty/March of Dimes: Screening for Genetic Diseases in Obstetrics AND Gynecology Grand Rounds, Department of Obstetrics & Gynecol­ogy. Madigan Army Medical Center. Tacoma, WA.

91.              Bombard, AT (1997): Maternal Serum Screening for Chromosomal Abnormalities Other than Down Syndrome (PL-25); Using Maternal Serum Screening as a Predictor for Adverse Perinatal Outcome: U.S. Experience (PL-31). Second Annual Asian Congress on Down Syndrome Screening. Taipei, Taiwan.

92.              Bombard, AT (1997): Coordinating Laboratory and Clinical Services into Comprehen­sive Maternal Screening Programs: Development of a Regional Network. Seoul Perinatal Consortium Luncheon. Seoul, Korea.

93.              Prenatal screening for Down syndrome: What primary care givers don’t know. SJ Gross, DJ Cardeiro, AT Bombard. Proceedings of the 4th Annual Joint Clinical Genetics Meeting of the March of Dimes and the American College of Medical Genetics. Ft. Lauderdale, Florida.

94.              Bombard AT (1997): Invited Faculty: Screening for Genetic Disease in Pregnancy. 45th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Las Vegas, Nevada.

95.              Kellner, LH, Bombard AT (1997): Urinary markers: New approach in screening for fetal Down syndrome in the second trimester. South East Regional Genetics Group (SERGG) meeting; July, 1996. Ft Walton Beach, FL and the Proc Greenwood Genet Cen. Process Greenwood Gen Cen 16:273.

96.              Bombard, AT (1997): Autumn in New York: “Bringing Care to Women Through Innovations in Screening: Genetics and Other New Developments.” Course Director. November 22-23; New York Helmsley Hotel. New York, NY.

97.              Bombard AT (1998): Invited Faculty: Reproductive Genetics in the Age of Managed Care. Genzyme Corporation/Genzyme Genetics National Annual Sales Meeting. Austin, TX.

98.              Bombard AT (1998): Invited Faculty: Screening for Genetic Disease in Pregnancy. And Managed Care in Ob-Gyn. 46th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. New Orleans, Louisiana.

99.              Bombard AT (1998): Invited Faculty: Reproductive Medicine in an Era of Managed Care. University of South Florida Conference: “How should Maternal & Child Services be delivered in the 21st Century?” Tampa, Florida.

100.          Bombard AT (1999): Invited Faculty: BRCA Screening: Navigating Insurance Waters. Cancer Genetics Satellite Symposium. Annual Meeting of the American Society of Clinical Oncology. Atlanta, Georgia.

101.          Bombard AT (1999): Invited Faculty: Managed Care in Obstetrics & Gynecology Practice. 47th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Philadelphia, Pennsylvania.

 

102.          Bombard AT (1999): Invited Faculty: Implementing a BRCA Screening Program: Innovations from the Insurance Industry Perspective. Department of Defense, Armed Forces Institute of Pathology Mini-Course on Hereditary Cancer, Risk Assessment, and Services. Rockville, Maryland.

103.          Bombard AT (1999): Invited Faculty: BRCA Screening: Navigating Insurance Waters. Department of Obstetrics and Gynecology Grand Rounds. St Louis University. St Louis, Missouri.

104.          Bombard AT (1999): Invited Faculty: Screening for Genetic Disease in Obstetrics & Gynecology and Obstetrics and Gynecology: The Business Side of Disease Screening and Testing. 20th Annual Daniel K. Roberts Ob-Gyn Update. “The Female Patient: Contemporary Issues.” Department of Obstetrics and Gynecology; University of Kansas School of Medicine/Wesley Medical Center. Wichita, Kansas.

105.          Bombard AT (1999): Implementing a BRCA Screening Program: Innovations in Health Care Delivery – An Insurance Perspective. 49th Annual Meeting of the American Society of Human Genetics. San Francisco, California.

106.          Bombard AT (2000): Invited Faculty: Understanding the Insurance Industry. 48th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. San Francisco, California.

107.          Bombard AT (2000): Invited Faculty: Great Expectations: Practice Management Essentials for Obstetrics & Gynecology Residents. The Ob/Gyn and Managed Care. San Francisco, California.

108.          Bombard AT (2000): Invited Faculty: Genetic Testing for Cancer: Who to Test, When to Test, and Who Will Pay for It. 36th Annual Meeting of the American Society of Clinical Oncology. New Orleans, Louisiana.

109.          Bombard AT (2000): Invited Faculty: State of the Art in Cancer Risk Assessment and Prevention. The University of Chicago. Chicago, Illinois.

110.          Bombard AT (2000): Invited Faculty: Navigating the Healthcare System. Bringing the 22q11.2 Deletion Into the 21st Century; Second International Conference for Families and Professionals. Philadelphia, Pennsylvania.

111.          Bombard AT (2000): Invited Faculty: Genetics and the Insurance Industry. Department of Obstetrics & Gynecology Grand Rounds, Saint Barnabas Medical Center. Livingston, NJ.

112.          Bombard AT (2000): Invited Faculty: Update on Genetic Advances in the Last 5 Years and Application and Implication of Genetic Advances. Smart Art: From Physiology to Clinical Success. Chicago, Illinois.

113.          Bombard AT (2000): Invited Speaker: Coverage Policy Development: Applications to Molecular Susceptibility Testing for Hereditary Breast/Ovarian Cancer. The American Jewish Congress. New York, New York.

114.          Bombard AT (2000): Invited Speaker: Molecular Susceptibility Testing for Hereditary Breast/Ovarian Cancer.  Department of Hematology/Oncology. Tufts New England medical Center. Boston, Massachusetts.

 

115.          Bombard AT, Cohen AW, Frank TS, Deffenbaugh A (2000): Screening individuals at risk for breast or ovarian cancer by BRCA 1/2 mutation analysis: Experience from a national, comprehensive educational program. 50th Annual Meeting of the American Society of Human Genetics. Philadelphia, Pennsylvania. Am J Hum Genet 67(4):80 (S368).

116.          Bombard AT (2000): Invited Briefer. U.S. Department of Health and Human Services. Secretary’s Advisory Committee on Genetic Testing. National Institutes of Health. Bethesda, Maryland.

117.          Bombard AT, Breitenstein AG, Rothstein MA, Welch CA, Zittrain J (2001): Harvard Health Caucus Symposium Speaker: Genetic Privacy: Legal and Ethical Frameworks. Harvard Law School. Cambridge, Massachusetts.

118.          Bombard AT (2001): Invited Faculty: Understanding (and Navigating) the Health Insurance Industry. 49th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists. Chicago, Illinois.

119.          Bombard AT (2001): Invited Faculty: Great Expectations: Practice Management Essentials for Obstetrics & Gynecology Residents. The Ob/Gyn and Managed Care: What You Need to Know to Benefit Your Patients. Chicago, Illinois.

120.          Bombard AT (2001): Invited Faculty: What Can We Expect of Genetic Medicine? What Health Plans Need to Know – Benefit Design/Coverage Considerations. American Association of Health Plans 2001 Managed Care Institute & Forum. Los Angeles, California.

121.          Bombard AT (2001): Invited Faculty: The Business of Medicine: Survival After Your Residency. Grand Rounds, Bronx-Lebanon Medical Center. Bronx, New York.

122.          Bombard AT (2001): Invited Speaker: Genetics and Health Insurance. AMA Conference on the Convergence of Genetics, CME, and Performance Measures. Chicago, IL.

123.          Cutillo D, Ramsey D, Cohen A, Bombard AT, Bhatt S, Donnenfeld AE, and Weinblatt VJ (2002): Risk factors identified through genetic counseling: The value of a comprehensive risk assessment. Proceedings of the Annual Clinical Meeting of the American College of Medical Genetics. 

124.          Armstrong JC, Cohen AW, Bombard AT, Bondi R (2002): Comparison of Amniocentesis-related Loss Rates between Obstetrician-Gynecologists and Perinatologists in a Managed Care Population. Proceedings of the 50th Annual Clinical Meeting of the American College of Obstetricians and Gynecolo­gists.

125.          Bombard AT (2002): Invited Faculty: Genetic Screening: When, What, and How; Down Syndrome Screening: First or Second Trimester: How and Who?; Using Society Guidelines to Guide Care. ACOG Post Graduate Course “Office Obstetrics & Gynecology.” Toronto, ON.

126.          Bombard AT (2002): Invited Faculty: Genetic Screening. ACOG District VII, 45th Annual Meeting. New Orleans, Louisiana.

127.          Bombard AT (2002): Invited Faculty Understanding Managed Care – “Insurance 101.” Department of Obstetrics & Gynecology Grand Rounds, SUNY Downstate Medical Center. Brooklyn, New York.

128.          Bombard AT (2002): Invited Faculty Understanding Managed Care – “Insurance 101.” Department of Obstetrics & Gynecology Grand Rounds, Lenox Hill Hospital. New York, New York.

129.          Bombard AT (2003): Invited Faculty Genetic Testing and Reproductive Decisionmaking: Financial Considerations. Genetics & Public Policy Center “Reproductive Genetics Policy: Framing the Issues.” Washington, DC.

130.          Bombard AT (2003): Invited Faculty Understanding Managed Care – “Insurance 101.” Department of Obstetrics & Gynecology Grand Rounds, Jamaica Hospital Medical Center. Queens, New York.

131.          Bombard AT (2003): Invited Faculty Understanding Managed Care – “Insurance 101.” Department of Obstetrics & Gynecology Grand Rounds, Maimonides Medical Center. Brooklyn, New York.

132.          Bombard AT (2003): Invited Faculty Understanding Managed Care – “Insurance 101.” Department of Obstetrics & Gynecology Grand Rounds, Cornell University Medical Center. New York, New York.

133.          Bombard AT (2003): Invited Faculty Genetic Screening in Contemporary Obstetric Practice. Department of Obstetrics & Gynecology Grand Rounds, Staten Island University Hospital. Staten Island, New York.

134.          Bombard AT (2003): Course Director, American College of Obstetricians & Gynecologists Annual Clinical Meeting “Mid-Career Transitions: Is the Grass Greener.” Invited Faculty. The Role of the Medical Director in Health Plans. Insurance 101: Financing Health Care. Insurance 102: Effecting Change. New Orleans, Louisiana.

135.          Bombard AT (2003): Invited Faculty Genetics & Prenatal Diagnosis. SUNY Downstate Medical Center 5th Annual Comprehensive Review Course in Obstetrics & Gynecology. Brooklyn, NY.

136.          Bombard AT (2003): Invited Faculty Screening for Genetic Diseases and The Business of Health Care. University of Tennessee 50th Annual Summer Conference. Chattanooga, TN.

137.          Weiner Z, Hamisa R, Fisher A, Bombard A, and Shalev E (2004): The effect of steroids on the fetal brain, umbilical blood flow, and the biophysical profile. Am J Obstet Gynecol 189(6):S218.

138.          Kellner L, Weiner Z, and Bombard A (2004): Continuous quality improvement (CQI) of nuchal translucency imaging: interaction between sonographers and the laboratory. Am J Obstet Gynecol 189(6):S240.

139.          Bombard AT (2004): Invited Faculty: Update on Prenatal Diagnosis. Proceedings of the 650th Meeting of the Medical Club of Brooklyn. Brooklyn, New York.

140.          Venegas J, Fisher A, Weiner Z, Bombard A (2004): Clinical versus sonographic evidence of fetal weight performed in labor and delivery prior to labor. Award Recipient, Resident Research Night, Brooklyn Gynecological Society. Brooklyn, New York

141.          Dudbhai M, Fisher A, Weiner Z, Bombard A (2004): Patients’ attitudes toward prenatal diagnosis of fetal anomalies. Award Recipient, Resident Research Night, Brooklyn Gynecological Society. Brooklyn, New York.

142.          Bombard AT (2004): Course Director, Lutheran Medical Center and Lenetix Medical Laboratories: “First and Second Trimester Screening for Down Syndrome.” Brooklyn, NY.

143.          Bombard AT (2004): Invited Faculty “ACGME Competencies - Resident Training in Practice-Based Learning and Systems-Based Practice: Fundamentals of Healthcare Financing.” Department of Obstetrics & Gynecology Grand Rounds, SUNY Downstate Medical Center. Brooklyn, New York.

144.          Bombard AT (2004): Invited Faculty “Predictive Genetic Testing: The Managed Care Perspective” New York State Genetics Task Force Meeting. New York, New York.

145.          Noumi G, Venegas J, Bombard A, Weiner Z (2005): Clinical and sonographic estimation of fetal weight performed by residents during the active phase of labor. Society of Maternal-Fetal Medicine meeting. Am J Obstet Gynecol 191(6): S83, #274.

146.          Dudhbhai M, Fisher A, Bombard A, Julliard K, Weiner Z (2005): Pregnancy outcome in patients with abnormal glucose challenge test and normal oral glucose tolerance test: Comparison with normal and gestational diabetic patients. Society of Maternal-Fetal Medicine meeting. Am J Obstet Gynecol 191(6): S54, #162.

147.          Collado F, Bombard A, Li V, Julliard K, Weiner Z (2005): Ethnic variation of fetal nasal bone length between 11-14 weeks’ gestation. Society of Maternal-Fetal Medicine meeting. Am J Obstet Gynecol 191(6): S146, #512.

148.          Yan-Rosenberg L, Burt S, Collado-Khoury F, Sharet L, Bombard A, Weiner Z (2005): Effect of maternal hydration on the AFI in women with oligohydramnios. Am J Obstet Gynecol 193(6): S101, #327.

149.          Weiner Z, Dudhbhai M, Bhillakar M, Bombard A (2005): Correlation between intrapartum fetal heart rate pattern and umbilical cord arterial blood gases in low-risk patients. Am J Obstet Gynecol 193(6): S104, #341.

150.          Rottem S, Sood R, Birnholz J, Jaffe R, Bombard A, Lysikiewitch A, Macedonia C, Anyane-Yeboa K (2005): Time oriented detection of sonographical markers of 228 syndromes, sequences and associations at 6-16 wks scan. Proceedings of the Am College of Medical Genetics. San Diego, California.

151.          Bombard AT (2006): Invited Faculty “Health insurance and the provision of genetics services.” Presidential Symposium Plenary Session. The Annual Meeting of the American College of Medical Genetics. San Diego, California.

152.          Catanzarite V, Byrd K,McNamara M, Bombard A (2006): Preventing needlestick injuries in obstetrics and gynecology: Assessing the penetration of blunt tip needles into practice. Proceedings of the 44th Annual ACOG Armed Forces District Meeting. Sonthofen, Germany.

153.          Weiner Z, Weizman B, Goldstein I, Beloosesky R, Bombard A. (2007): Fetal cardiac scanning performed immediately following an abnormal NT examination. Am J Obstet Gynecol 197(6): S57, #163.

154.          Brown S, Kellner L, Munson M, Yang Y, Klotzle B, Bombard A (2007): Non-invasive prenatal testing: Technical strategies to achieve testing of cell free fetal DNA (cFFDNA) RhD genotype in a clinical lab. Am J Obstet Gynecol 197(6): S173, #603.

 

 


Scientific Publications:

 

1.                  Makheja AN, Bombard AT, Randazzo RL, Bailey JM (1978): Anti­‑inflammatory drugs in experimental atherosclerosis. Part 3. Evalua­tion of the atherogenicity of homocys­tine in rabbits. Athero­sclerosis. 29:105.

2.                  Bailey JM, Watson R, Bombard AT, Randazzo RL (1984): Anti­‑inflam­matory drugs in experimental atheroscler­osis. Part 5. Influence of cortisone acetate on short term and long term cholesterol fluxes in atherosclerotic aortae. Atherosclero­sis 51 (2‑3):299.

3.                  Bombard AT, (1985): Collected Letters: Early detection of microcepha­ly. Internation­al Correspon­dence Society of Ob­ste­tri­cians and Gyne­colog­ists. 26(14):103‑4.

4.                  Bombard AT, Simpson JL, Elias S, and Martin AO (198­6): Symposium: Medical Genetics II. Chorionic villus sampling: First trimester prenatal diagnosis. India J Pediatr 53:747‑759.

5.                  Bombard AT, Elias S (1986): Genetic disease: New tests for high­-risk couples. Diagnosis 8(10):67‑­82.

6.                  Elias S, Simpson JL, Martin AO, Sabbagha RE, Bombard AT, Rosinsky BJ, and Baum LD (1986): Chori­onic villus sam­pling in continuing pregnancies. I. Low fetal loss rates in ini­tial 109 cases. Am J Obstet Gynecol 154:1349-­13­52.

7.                  Martin AO, Elias S, Rosinsky BJ, Bombard AT, Simpson JL (1986): False negative findings on chorionic villus sam­pling. Lancet 2:391‑392.

8.                  Ober C, Bombard AT, Dhaliwal R, Elias S, Fagan J, Laf­fler T, Martin A, and Rosinsky B (1987): Studies of cystic fibrosis in Hut­terite families using linked DNA probes. Am J Hum Genet 41(6):1145.

9.                  Verp MS, Bombard AT, Simpson JL, Elias S and Martin AO (1988): Parental decision following prenatal diagnosis of fetal chromo­some abnor­malities. Am J Med Genet 29:613-622.

10.              Bombard AT (1988): Antenatal diagnosis for the clinician. J MS State Med Assn 29(10):307-311.

11.              Bombard AT, Strickland DM, Hauth JC, Trabal JF, Mitchell MD (1988): Prostaglandin E metabo­lite in peritoneal fluid of women with endometriosis. Med Sci Res 16:527-528.

12.              Bombard AT (1988): Kallman syndrome and anosmia in military aircrews. Military Medicine 153(11):596.

13.              Bombard AT, Bartholomew DW, and Rigdon DT (1988): Dif­feren­tial diagnosis of homocystinuria. Military Medicine 153(11):596.

14.              Bombard AT, Rigdon, DT, and Flanagan, JC (1989): Maternal serum alpha-fetoprotein screening: The Keesler experience. Military Medicine 154(4):206-209.

15.              Bombard AT: Clinical perspectives on neural tube defects. Med Bull PB 8-89-9/10:14-17

16.              Bombard AT, Rigdon DT, Roberts WE, and Anderson RL (1989): Antena­tal assessment and management of an incom­plete obstructive fetal uropathy. J MS State Med Assn 30(10):317-320.

17.              Ober C, Elias S, O’Brien E, Kostyu D, Hauck W, and Bom­bard A (1989): HLA sharing and fertility in Hutterite couples: Evidence for prenatal selec­tion against compatible fetuses. Am J Reprod Immunol Microbiol 18:111-115.

18.              Bombard AT (1990): MSAFP Screening: An Unrequited Love? Military Medicine 155(3):A7.

19.              Bombard AT, Rigdon DT, Bartholomew DB, Flanagan JC (1990): Analysis of indications for referral to a multi­disci­plinary medical genetics clinic: Implications for training programs in obstetrics and gynecology. Am J Obstet Gynecol 162 (1): 10-14.

20.              McCool RA and Bombard AT (1990): Assessment of obstet­ric ultrasound services in a ter­tiary mili­tary medical referral center. S Med J 83(7): 756-758.

21.              Bombard AT, Britton LC, Rigdon DT, and Maha GC (1990): Reduced amniotic fluid alpha-fetoprotein (AF-AFP) signals an increased risk for fetal aneuploi­dy. Applied Cytogenetics, 16(3):41-43.

22.              Bom­bard AT, Williams TC, Rigdon DT, and Bartholomew DW (1990): Effi­ciency of amniocyte karyotyping: A prospective comparison of the in-situ method with traditional cell culture technique. Applied Cytogenetics 16(5): 112-114.

23.              Strickland DM, Bombard AT, Trabal JF, and Mitchell M (1990): The modulation of prostaglandin synthesis by peritoneal fluids. Prostaglandins. 40:331-335.

24.              Naef R, Bombard AT, Pruitt L, Rigdon DT, and Bartholomew DW (1991): Fetal ultrasound abnormalities and risk for chromosome aberrations: Fetal ascites, pleural effusion and IUGR associated with trisomy 18. Applied Cytogenetics. 17(1):7-9.

25.              Bombard AT and Bartholomew DW (1991): Molecular analysis and chorionic villus sampling (CVS): Opportunities for rapid prenatal diagnosis in the military. Military Medicine. 156 (12): 678-680.

26.              Bombard AT and Rigdon DT (1992): A prospective pilot evaluation of early (11-14 weeks’ gestation) amniocentesis in 75 patients. Military Medicine 157 (7):339-341.

27.              McCool RA, Bombard AT, Locker BK, and Calhoun BC (1992): The association of unex­plained/elevated MSAFP (Maternal Serum Alpha-FetoProtein) screening and placenta increta: A case report. J Repr Med 37:826-828.

28.              Bombard AT (1992): Current Concepts in Prenatal Diagnosis (1992). J US Army Med Dept 

29.              Calhoun BC, Bombard AT (1992): Improving emergency transport for patient access and residency training. Military Med 157:A7.

30.              Bombard AT (1993): Evaluation of the female patient with a 46, XY chromosomal complement. Internation­al Correspon­dence Society of Ob­ste­tri­cians and Gyne­colog­ists. Int Corr Soc Ob Gyn. 34(8).

31.              Calhoun BC, Brehm W, Bombard AT (1994): Early genetic amniocentesis and its relationship to respiratory difficulties in paediatric patients: A report of findings in patients and matched controls 3-5 years post-procedure. Prenat Diagn 14(3):209-212.

32.              Weinbaum PJ, Bombard AT, Phillips OP (1994): CVS versus Amniocentesis. ACOG Update #19.

33.              Bombard AT, Nakagawa S, Runowicz CD, Cohen BL, Mikhail MS, Nitowsky HM (1994): Early detection of abdominal pregnancy by maternal serum oncofetal antigen screening. Prenat Diagn. 14:1155-1157.

34.              Bombard, AT (1994): The Strategic Air and Sea Campaign Against Japan During World War II, 1942-1945. Air War College Study Project. Air University, Maxwell Air Force Base, Al.

35.              Bombard AT, Carter SM, Nitowsky HM (1994): Early amniocentesis versus chorionic villus sampling for fetal karyotype. Lancet 344:826.

36.              Javed AA, Huang Y, and Bombard AT (1995): Molecular analysis of genetic diseases: A guide for practicing clinicians. Anyaegbunam, AM (Ed). J Assoc for Acad Minority Physicians. 6(1):15-27.

37.              Bombard AT, Powers JF, Carter SM, Schwartz A, Nitowsky HM (1995): Procedure-related fetal losses in transplacental versus non-transplacental genetic amniocentesis. Am J Obstet Gynecol. 172 (3): 868-872.

38.              Rappoport P, Sicherman N, Bombard AT (1995): Current maternal age recom­mendations for prenatal diagnosis: A reappraisal using expected utility theory. Fetal Diagn Ther. 10(3):157-167.

39.              Bombard AT, Powers JF, Carter SM, Schwartz A, Nitowsky HM (1995): Procedure-related fetal losses in transplacental versus non-transplacental genetic amniocentesis. ACOG Current Journal Review 8(5):47.

40.              Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin G, Mueenuddin M, Bombard A (1995): Triple marker (AFP, uE3, hCG) screening versus AFP plus free-beta in second trimester maternal serum screening for Down syndrome: A prospective comparison study. Am J Obstet Gynecol 173(4):1306-1309.

41.              Calhoun BC, Bombard AT, Brehm W, Roberts WE (1995): Management of immune thrombocytopenic purpura (ITP) at a Military Medical Center. Milit Med. 160(12):620-624.

42.              Carter SM, Bombard AT, Sachs GS, Finn-Powers JM, Schwartz AD (1996): Does the presence of occult subchorionic hematomas influence outcome following genetic amniocentesis? Milit Med 161(4):243-245.

43.              Sherer DM, Bombard AT, Kellner LH, Divon MY (1996): Non-invasive first-trimester screening for fetal aneuploidy: A review. Obstet Gynecol Surv 52(2):123-129.

44.              Kellner LH, Ferreira JCP, Bombard, AT (1997): Neutrophil alkaline phosphatase: Where do we go from here? Proceedings of the International Conference: Down Syndrome Screening Policy and Economic Evaluation. National School of Public Health. Athens, Greece.

45.              Kellner LH, Canick JA, Palomaki GE, Neveaux LM, Saller DN, Walker RP, Osathan­ondh R, Bombard AT (1997): Levels of urinary beta-core fragment, total estriol and the ratio of the two in second trimester screening for Down syndrome. Prenat Diagn 17:12:1135-1141.

46.              Bombard AT, Kellner LH, Kapel AS, Brown MA, Merkatz IR, Nitowsky HM (1997): Re-engineering the academic medical center: Reproductive genetics as a model for implementing consumer-focused services. GENES Newsletter.

 

47.              Freda MC, DeVore N, Valentine-Adams N, Bombard A, Merkatz IR (1998): Informed consent for maternal serum screening in an inner city population: How informed is it? JOGNN 27:99-106.

48.              Leibowitz A, Cohen AW, Bombard AT (1998): Management of Women at Risk for Breast Cancer (BRCA Testing, Prophylactic Mastectomy, Tamoxifen). Aetna U.S. Healthcare Coverage Policy Bulletin #227.

49.              Leibowitz A, Cohen AW, Bombard AT (1999): Coverage of Preconceptional Sex Selection Techniques. Aetna U.S. Healthcare Coverage Policy Bulletin #323.

50.              Leibowitz A, Cohen AW, Bombard AT (1999): Genetic Testing. Aetna U.S. Healthcare Coverage Policy Bulletin #140.

51.              Leibowitz A, Cohen AW, Bombard AT (1999): Down syndrome screening by ultrasonographic assessment of fetal nuchal thickening (NT). Aetna U.S. Healthcare Coverage Policy Bulletin #282.

52.              Leibowitz A, Cohen AW, Bombard AT (1999): Coverage of Preimplantation Genetic Testing. Aetna U.S. Healthcare Coverage Policy Bulletin.

53.              Leibowitz A, Cohen AW, Bombard AT (1999): Coverage of Prenatal Diagnosis for Fetal Genetic Disease. Aetna U.S. Healthcare Coverage Policy Bulletin.

54.              Armstrong J, Bombard AT (2001): Genetic Breast Cancer Susceptibility Testing. In “Women’s Health Advances Today: Breast Cancer.” Am Assoc Health Plans. Fall 2001.

55.              Bombard A, Cohen AW. (Winter/Spring 2002). Privacy and Preventive Health Care: Integrating Coverage of Genetic Technologies into Health Care Policies. Harvard Health Caucus: Working Paper Series, The Social Implications of the Human Genome Project. Available online at: http://web.med.harvard.edu/healthcaucus/ 

56.              Bombard AT (2002): Letter to the Editor: Insurance Justification Letters. J Genet Coun 11(1):75.

57.              Venegas G, Khoury E, Bombard AT (2002): Prenatal screening for fetal Down syndrome. Women’s Health Advances Today magazine (American Association of Health Plans publication). November.

58.              Collado FK, Fisher AJ, Bombard AT (2003): Counseling the Patient with Trisomy 17 Mosaicism Found at Genetic Amniocentesis. Prenat Diagn 23(11):948-950.

59.              Collado FK, Bombard AT (2004): Hereditary breast and ovarian cancer: What the primary care physician should know. Obstet Gynecol Surv. 59 (7):537-542.

60.              Bombard AT: Determining the utility of clinical tests – NCCLS Guideline. Indications for use: Prenatal Diagnosis (in press). 

61.              Collado FK, Anderson V, Haas B, Fisher AJ, Bombard AT, Weiner Z (2004): Trisomy 9 screened positive for trisomy 18 maternal serum screening. Prenat Diagn 24 (10):836-838.

 

62.              Collado F, Bombard A, Li Vi, Julliard K, Aptekar L, and Weiner Z (2005): Ethnic variation of fetal nasal bone length between 11-14 weeks' gestation. Prenat Diagn. 25:690-692.

63.              Noumi G, Collado-Khoury F, Bombard AT, Julliard K, Weiner Z (2005): Clinical and sonographic estimation of fetal weight performed by residents during the active phase of labor. Am J Obstet Gynecol 192:1407-9.

64.              Khoury-Collado F, Fisher AJ, Bombard AT, Weiner Z (2005): Prenatal Diagnosis of 47,XXX Am J Obstet Gynecol 192:1469-71.

65.              Yan-Rosenberg L, Burt S, Collado-Khoury F, Sharet L, Bombard A, Weiner Z (2005): Effect of maternal hydration on the AFI in women with oligohydramnios. Am J Obstet Gynecol. 193 (6):S101.

66.              Weiner Z, Dudhbhai M, Bhillakar M, Bombard A. (2005): Correlation between intrapartum fetal heart rate pattern and umbilical cord arterial blood gases in low-risk patients. Am J Obstet Gynecol. 193 (6):S341.

67.              Dudhbhai M, Lim L, Bombard A, Julliard K, Meenakshi B, Trachtenberg Y, Weiner Z (2006): Characteristics of patients with abnormal glucose challenge test (GCT) and normal glucose tolerance test (OGTT): comparison with normal and gestational diabetic patients. Am J Obstet Gynecol May;194(5):e42-5.

68.              Lim L, Aptekar L, Bombard A, Juliard K, Meenakshi B, Weiner Z (2006): Ethnicity and other factors that may affect the prevalence of echogenic intracardiac foci in the fetus. J Clin Ultrasound Sep;34(7):327-9.

69.              Weiner Z, Goldstein I, Bombard A, Applewhite L, Itzkovitz-Eldor J (2007): Screening for structural fetal anomalies during the nuchal translucency ultrasound examination. Am J Obstet Gynecol;197:181.e1-181.e5.

70.              Clements CJ, Flohr-Rincon S, Bombard AT, Catanzarite V (2007): Ob Team Stat: Rapid response to obstetrical emergencies. Nursing for Women’s Health (AWHONN) 11(2):194-199.

71.              Catanzarite V, Almryde K, Bombard A (2007): Ob Team Stat: Developing a Better L&D Rapid Response Team. Contemp Ob/Gyn. September. Pp. 52-65.

72.              Rosenberg L, Burt S, Bombard, A, Collado-Khoury F, Sharett L, Julliard, K, Weiner Z (2007): A randomized clinical trial comparing the effect of maternal intravenous hydration and placebo on the amniotic fluid index in oligohydramnios. The Journal of Maternal-Fetal & Neonatal Medicine, 20(10), pp. 715 - 718.

73.              Weiner Z, Aptekar L, Muralikrishnan K, Bombard A: Prenatal sonographic findings by using two- and three-dimensional ultrasound in achondrogenesis. Prenat Diagn (in press).


Edited Works:

 

1.                  Simpson JL and Bombard AT (1987): Chromosomal abnor­mali­ties in spon­taneous abortions: Frequency, pathology, and genetic counseling in Edmonds, DK and Bennett, MJ [eds.] Spon­taneous Abor­tion. William Heineman Medical Books. Lon­don. 

2.                  Bombard AT and Naef RW (1993): Reproductive genetics for couples over forty. In Barad, D (Ed) Obstetrics and Gynecology Clinics of North America. Vol. 20 (2): 279-297. WB Saunders Company. Philadelphia, PA.

3.                  Bombard AT, Fields A, Aufox S, and Ben-Yishay M (1996): The genetics of ovarian cancer: An assessment of current screening protocols and recommendations for counseling families at risk. Clin Obstet Gynecol 39(4):860-872. JB Lippincott Company. Philadelphia, PA.

4.                  Elias S, Simpson, JL, Bombard AT (1998): Amniocentesis. In: Genetic disorders and the fetus: Diagnosis, prevention, and therapy, 4th ed. Milunsky A (ed). The Johns Hopkins University Press, Baltimore.

5.                  Gross SJ, Bombard AT (1998): Screening for the Aneuploid Fetus. In: Obstetrics and Gynecology Clinics of North America. Roberts WE and Perry K (eds). WB Saunders Company. Philadelphia, PA. 

6.                  Ferreira JCP, Sachs GS, Bombard AT (1999): Teratogenic Drugs. In: Complications of Pregnancy, 5th ed. Parisi V and Cohen WR (eds). JB Lippincott Company. Philadelphia, PA.

7.                  Kellner LH, Ferreira J, Bombard AT (1999): Neutrophil alkaline phosphatase: Where do we go from here? In: Down syndrome screening policy and economic evaluations; European group for Down syndrome. Beazoglou T, Benn P, Cuckle H, Haddow J, and Kyriopolous J (Eds). National School of Public Health & Exandas Publishers, Athens, GR.

8.                  Canick J, Kellner LH and Bombard AT (2003): Prenatal Screening for Open Fetal Defects. Clin Lab Med. 23(2):385-394. W. B. Saunders, Inc. Philadelphia, PA.

 

More Information About Dr. Allan Bombard

Allan T Bombard MD

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Contact

Sharp Mary Birch Hospital
3003 Health Center Drive
San Diego, CA 92123

Tel: 858.939.4167
Fax: 858.939.4983
allan.bombard@sharp.com